Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Minoxidil for Persistent Hair Loss in Pediatric and Young Adult Cancer Survivors
NCT05778825Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in alopecia comparing Oral Minoxidil with Placebo followed by oral Minoxidil (2 arms). Primary endpoints: Change in the target area hair density at 4 months and Change in the target area hair density at 8 months. Started Mar 2023; status: active, not recruiting.
02
Drugs
minoxidil
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT05778825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05778825.